Overview

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Status:
Not yet recruiting
Trial end date:
2025-02-10
Target enrollment:
Participant gender:
Summary
To determine the best method to prevent CINV caused by TC regimen in patients with gynecological malignant tumor.
Phase:
Phase 4
Details
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Treatments:
Aprepitant